IOBT - IO Biotech, Inc.

Stock Grade Analysis

General Rating

C+
Overall Score: 2/5
Multi-dimensional Scores
DCF: 3/5 ROE: 1/5 ROA: 1/5 D/E: 3/5 P/E: 1/5
Financial Ratios Trend

Grades Consensus

0

Strong Buy

5

Buy

0

Hold

0

Sell

0

Strong Sell

Buy

Consensus

Grade News & Updates

Date Grading Company New Grade Previous Grade Action Price When Posted News Title Publisher
2025-05-14 H.C. Wainwright Buy Buy Hold $0.98 IO Biotech price target raised to $14 from $12 at H.C. Wain… TheFly
2024-09-16 Morgan Stanley Overweight Overweight Hold $0.751 IO Biotech price target raised to $6 from $4 at Morgan Stan… TheFly
2024-09-03 Jefferies Buy Buy Hold $1.08 IO Biotech (IOBT) PT Lowered to $8 at Jefferies StreetInsider
2024-09-03 Piper Sandler Overweight Overweight Hold $1.08 Piper Sandler Reiterates Overweight Rating on IO Biotech (I… StreetInsider
2024-09-03 H.C. Wainwright Buy Buy Hold $1.07 H.C. Wainwright Reiterates Buy Rating on IO Biotech (IOBT) StreetInsider
2021-12-03 Morgan Stanley Overweight N/A Initialise $10.9 IO Biotech (IOBT) Stock: $21 Price Target From Morgan Stanl… Pulse 2.0